Diagnostic Microbiology and Infectious Disease

Article	Citations
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review	258
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)	78
The use of copper to help prevent transmission of SARS-coronavirus and influenza viruses. A general review	70
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays	51
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals	50
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection	44
Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center	44
Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples	38
COVID-19 in Brazil: 150,000 deaths and the Brazilian underreporting	38
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection	36
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type	36
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units	36
How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory	35
The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.	33
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities	32
COVID-19 – 6 million cases worldwide and an overview of the diagnosis in Brazil: a tragedy to be announced	31
Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19	28
Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study	28
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies	28
Activity of aztreonam in combination with ceftazidime–avibactam against serine- and metallo-β-lactamase–producing Pseudomonas aeruginosa	27
Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (	26
Changes in healthcare managing COVID and non–COVID-19 patients during the pandemic: striking the balance	26
Vaginal bacterial profiles of aerobic vaginitis: a case–control study	26
Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review	25
Laboratory evaluation of the BioFire FilmArray Pneumonia plus panel compared to conventional methods for the identification of bacteria in lower respiratory tract specimens: a prospective cross-sectio	25

Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples	25
Advances in rapid diagnostics for bloodstream infections	25
Heat inactivation decreases the qualitative real-time RT-PCR detection rates of clinical samples with high cycle threshold values in COVID-19	24
A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia	24
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection	24
Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals	24
Detection of SARS-CoV-2 IgG antibodies in dried blood spots	23
Development of XRM-MacConkey agar selective medium for the isolation of Escherichia albertii	22
Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel	22
In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitaliz	22
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018–2020)	21
Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire® FilmArray® pneumonia panel: a systematic review and meta-analysis	21
The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2	21
Prospective clinical validation of 3D printed nasopharyngeal swabs for diagnosis of COVID-19	20
Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave	20
Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing	19
Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008-2018	19
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test	19
SARS-CoV-2 IgG antibody responses in New York City	19
SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States	18
Time to positivity of acute and chronic periprosthetic joint infection cultures	18
A highly multiplexed melt-curve assay for detecting the most prevalent carbapenemase, ESBL, and AmpC genes	17
Diagnostic accuracy of 5 different brands of dengue virus non-structural protein 1 (NS1) antigen rapid diagnostic tests (RDT) in Indonesia	17
Difficult-to-treat pathogens significantly reduce infection resolution in periprosthetic joint infections	17
Respiratory bacterial pathogen spectrum among COVID-19 infected and non–COVID-19 virus infected pneumonia patients	17
Targeted next generation sequencing for elbow periprosthetic joint infection diagnosis	17
Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?	17
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii	16
Expanded sequential quadriplex real-time polymerase chain reaction (PCR) for identifying pneumococcal serotypes, penicillin susceptibility, and resistance markers	16
Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection	16
In vitro activity of Ceftazidime–Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019	16
Impact of FilmArray meningitis encephalitis panel on HSV testing and empiric acyclovir use in children beyond the neonatal period	15
Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens	15
Understanding false positives and the detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and BD MAX SARS-CoV-2 assays	15
Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia	15
Systematic analysis, identification, and use of CRISPR/Cas13a–associated crRNAs for sensitive and specific detection of the lcrV gene of Yersinia pestis	15
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report	15
Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case–control study	15
Dynamic of humoral response to SARS-CoV-2 anti-Nucleocapsid and Spike proteins after CoronaVac vaccination	15
Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia	15
Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5– and IMP-7–type carbapenemases in a tertiary hospital	14
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs	14
Streptococcus agalactiae infections and clinical relevance in adults, Thailand	14
Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables	14
Balamuthia mandrillaris encephalitis in a child: case report and literature review	14
A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease	14
Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014–2018): therapeutic options for multidrug-resis	14
Evaluation and comparison of automated and manual ELISA for diagnosis of chronic pulmonary aspergillosis (CPA) in Indonesia	14
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using	14
Proposed nomenclature or classification changes for bacteria of medical importance: taxonomic update 5	14

The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening	13
Intact pap2 downstream of mcr-1 appears to be required for colistin resistance	13
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection	13
Point-of-care tests for malaria: speeding up the diagnostics at the bedside and challenges in malaria cases detection	13
Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature	13
Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG	13
Evaluation of the Abbott PanbioTM COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians	13
Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients	13
In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017–2018	13
Comparison of Lowenstein-Jensen medium and MGIT culture system for recovery of Mycobacterium tuberculosis from abscess samples	13
In vitro activity of TNP-2092 against periprosthetic joint infection–associated staphylococci	13
Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value	13
Staphylococcus aureus whole genome sequence–based susceptibility and resistance prediction using a clinically amenable workflow	12
Respiratory co-infections with COVID-19 in the Veterans Health Administration, 2020	12
Ongoing dissemination of OXA-244 carbapenemase-producing Escherichia coli in Switzerland and their detection	12
A deletion in the N gene of SARS-CoV-2 may reduce test sensitivity for detection of SARS-CoV-2	12
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals	12
Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019	12
Evaluation of diagnostic accuracy of loop-mediated isothermal amplification method (LAMP) compared with polymerase chain reaction (PCR) for Leptospira spp. in clinical samples: a systematic review and	12
Microbiological diagnosis of Acanthamoebic keratitis: experience from tertiary care center of North India	12
Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients	11
Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?	11
Accelerating the global response against the exponentially growing COVID-19 outbreak through decent data sharing	11
Comparison of reverse-transcription qPCR and droplet digital PCR for the detection of SARS-CoV-2 in clinical specimens of hospitalized patients	11
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018–2022)	11
Impact of the FilmArray meningitis/encephalitis panel on antimicrobial duration among patients with suspected central nervous system infection	11
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China	11
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay	11
Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus	11
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test	11
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from Unit	10
Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays	10
A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect	10
In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae	10
How to estimate time of infection with Toxoplasma gondii in pregnant women. Use of specific IgG and IgM kinetics by 7 techniques on 691 sera	10
Detection of herpes simplex and varicella-zoster virus from skin lesions: comparison of RT-PCR and isothermal amplification for rapid identification	10
Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients	10
Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients	10
Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19	10
Performance characteristics of the high sensitivity Alinity i & ARCHITECT HBsAg Next Qualitative/Confirmatory assays	10
Staphylococcus pettenkoferi-positive Blood cultures in Hospitalized Patients in a Multi-site Tertiary Center	10
Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection	10
Development and validation of a new scoring system for the early diagnosis of tuberculous meningitis in adults	10
Abbott ID now COVID-19 assay performance: a year in review	10
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories	10
Negative impact of the COVID-19 pandemic on the timely diagnosis of tick-borne infections	10
Predictive ability of LRINEC score in the prediction of limb loss and mortality in diabetic foot infection	10
Assay dependence of long-term kinetics of SARS-CoV-2 antibodies	10
Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019	9
A deletion in the N gene may cause diagnostic escape in SARS-CoV-2 samples	9
Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases	9
Performance of a rapid antigen test for SARS-CoV-2 in Kenya	9
Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform	9
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years	9
Evaluation of observed and unobserved self-collection of saline gargle samples for the detection of SARS-CoV-2 in outpatients	9
In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States	9
Synergistic antibacterial effects of analgesics and antibiotics against Staphylococcus aureus	9
Plasma cell-free metagenomic next generation sequencing in the clinical setting for the diagnosis of infectious diseases: a systematic review and meta-analysis	9
Comparison of SARS-CoV-2 molecular detection in nasopharyngeal swab, saliva, and gargle samples	9
Catheter-related bloodstream infection due to Tsukamurella pulmonis identified by MALDI-TOF spectrometry, 16S rRNA gene sequencing, and secA1 gene sequencing in an immunocompromised child: a case repo	9
Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays	9
SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil	9
Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC)	9
Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.	9
A quantitative enzyme-linked immunoassay (ELISA) to approximate complement-fixing antibody titers in serum from patients with coccidioidomycosis	8
Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods	8
Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales	8
Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study	8
False-positive SARS-CoV-2 serology in 3 children with Kawasaki disease	8
Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study	8
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales	8
In vitro activity of ceftaroline and ceftobiprole against clinical isolates of Gram-positive bacteria from infective endocarditis: are these drugs potential options for the initial management of this	8
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012–2018)	8
Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant	8
Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response	8
Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia	8
Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity	8
In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates	8
SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays	8
Development of a recombinase polymerase amplification assay for rapid detection of Streptococcus suis type 2 in nasopharyngeal swab samples	8

In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD stud	8
Sensitivity and specificity of multibacillary and paucibacillary leprosy laboratory tests: A systematic review and meta-analysis	8
A systematic review and meta-analysis of studies on the diagnostic accuracy and screening of tests to detect antimicrobial resistance in leprosy	8
In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014–2017 and 2018	8
Evaluation of automated antigen detection test for detection of SARS-CoV-2	7
Rapid qualitative antibiotic resistance characterization using VITEK MS	7
Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system	7
Detection of potential enteric pathogens in children with severe acute gastroenteritis using the filmarray: Results from a three - years hospital-based survey in Northern Italy	7
Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2	7
Validation of SARS CoV-2 detection by real-time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: a study in tertiary care hospital of North India	7
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011–2018	7
Pooling samples: a testing option for SARS-CoV-2 during a supply shortage	7
Intestinal carriage of colistin resistant Enterobacteriaceae in hospitalized patients from an Indian center	7
Clinical evaluation of nasopharyngeal, midturbinate nasal and oropharyngeal swabs for the detection of SARS-CoV-2	7
Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department	7
A case series of patients with Gemella endocarditis	7
Distribution of genes encoding 16S rRNA methyltransferase in plazomicin-nonsusceptible carbapenemase-producing Enterobacterales in Brazil	7
Risk factors for focal involvement in brucellosis	7
Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19	7
Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx)	7
Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France	7
Clinical impact of implementation of rapid diagnostic testing of blood cultures with Staphylococcus aureus on patient outcomes	7
Emergence and onward transmission of a SARS-CoV-2 E484K variant among household contacts of a bamlanivimab-treated patient	7
Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs	7
Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma	7
Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis	7
Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease	7
Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort	7
Coinfections among hospitalized patients with covid-19 in the first pandemic wave	7
In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis	7
Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence	7
The impact of rapid diagnostic testing, surveillance software, and clinical pharmacist staffing at a large community hospital in the management of Gram-negative bloodstream infections	7
The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis	7
Development and evaluation of a multiplex conventional reverse-transcription polymerase chain reaction assay for detection of common viral pathogens causing acute gastroenteritis	7
IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination	6
Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2	6
Screening methods for intestinal carriage of multidrug-resistant Enterobacterales: interest of enrichment broth	6
The challenge of COVID-19 for a Clinical Microbiology Department	6
Comparison of PCV-10 and PCV-13 vaccine coverage for invasive pneumococcal isolates obtained across Canadian geographic regions, SAVE 2011 to 2017	6
Genotypic characterization of ‘inferred’ rifampin mutations in GenoType MTBDRplus assay and its association with phenotypic susceptibility testing of Mycobacterium tuberculosis.	6
Extractionless nucleic acid detection: a high capacity solution to COVID-19 testing	6
Rare Lelliottia nimipressuralis from a wound infection case report using whole genome sequencing-based bacterial identification	6
Performance of ceftriaxone susceptibility testing on the Accelerate Pheno® system of ESBL-producing isolates	6
The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation	6
Polymyxin B broth disk elution: a feasible and accurate methodology to determine polymyxin B susceptibility in Enterobacterales	6
Rapid identification of the vanA/vanB resistance determinant in Enterococcus sp. from blood cultures using the Cepheid Xpert vanA/vanB cartridge system	6
Surgical infective endocarditis and concurrent splenic abscess requiring splenectomy: a case series and review of the literature	6
Comparison of mortality, stroke, and relapse for methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infective endocarditis: a retrospective cohort study	6
Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients	6
Molecular detection of Mycobacterium tuberculosis in blood stained sputum samples using GeneXpert PCR assay	6
Fast and reliable detection of carbapenemase genes in various Gram negatives using a new commercially available fluorescence-based real-time polymerase chain reaction platform	6
SARS-CoV-2 diagnostics: Some reflections on current assays	6
Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2	6
Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 – 2020	6
In vitro susceptibility testing of ceftobiprole against 880 European respiratory tract infection isolates of methicillin-resistant Staphylococcus aureus followed by whole genome sequencing of ceftobip	6
Clinical evaluation of the ResistancePlus MG FleXible test on the GeneXpert Infinity-48s instrument: a near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance	6
Core genome MLST and resistome analysis of Klebsiella pneumoniae using a clinically amenable workflow	6
Evaluation of a PCR-electrospray ionization mass spectrometry platform for detection and identification of fungal pathogens directly from prospectively collected bronchoalveolar lavage specimens	6
Development of a species-specific real-time PCR test for Chlamydia psittaci and its employment in the investigation of zoonotic transmission from racing pigeons in Denmark	6